Artivion Inc - Asset Resilience Ratio
Artivion Inc (AORT) has an Asset Resilience Ratio of 0.07% as of September 2021. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital to net assets of Artivion Inc to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1999–2020)
This chart shows how Artivion Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see AORT total assets.
Liquid Assets Composition Over Time
This chart breaks down Artivion Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read AORT total debt and obligations for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $538.00K | 0.07% |
| Total Liquid Assets | $538.00K | 0.07% |
Asset Resilience Insights
- Limited Liquidity: Artivion Inc maintains only 0.07% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Artivion Inc Industry Peers by Asset Resilience Ratio
Compare Artivion Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
TransMedics Group Inc
NASDAQ:TMDX |
Medical Devices | 0.00% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Novocure Ltd
NASDAQ:NVCR |
Medical Devices | 43.72% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
Hangzhou AGS MedTech Co. Ltd. A
SHG:688581 |
Medical Devices | 18.80% |
|
Nanjing Vishee Medical Technology Co Ltd
SHG:688580 |
Medical Devices | 10.74% |
|
Nanjing Medlander Medical Technology Co. Ltd. A
SHG:688273 |
Medical Devices | 34.29% |
Annual Asset Resilience Ratio for Artivion Inc (1999–2020)
The table below shows the annual Asset Resilience Ratio data for Artivion Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2020-12-31 | 0.07% | $546.00K | $789.40 Million | -0.02pp |
| 2019-12-31 | 0.09% | $528.00K | $605.65 Million | -0.04pp |
| 2018-12-31 | 0.13% | $747.00K | $571.09 Million | 0.00pp |
| 2017-12-31 | 0.13% | $776.00K | $591.67 Million | -0.09pp |
| 2016-12-31 | 0.22% | $699.00K | $316.14 Million | -0.24pp |
| 2015-12-31 | 0.46% | $830.00K | $181.18 Million | -2.76pp |
| 2007-12-31 | 3.22% | $2.99 Million | $92.68 Million | -1.74pp |
| 2006-12-31 | 4.96% | $3.96 Million | $79.86 Million | -1.50pp |
| 2005-12-31 | 6.47% | $4.97 Million | $76.81 Million | +1.07pp |
| 2004-12-31 | 5.40% | $3.96 Million | $73.26 Million | -1.63pp |
| 2003-12-31 | 7.03% | $5.27 Million | $75.03 Million | -6.68pp |
| 2002-12-31 | 13.70% | $14.58 Million | $106.41 Million | -6.78pp |
| 2001-12-31 | 20.48% | $26.48 Million | $129.31 Million | +1.52pp |
| 2000-12-31 | 18.96% | $21.23 Million | $112.01 Million | -7.00pp |
| 1999-12-31 | 25.95% | $24.40 Million | $94.03 Million | -- |
About Artivion Inc
Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers On-X prosthetic aortic and mitral heart valves; On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters; Chord-X ePTFE sutures; pyrolytic carbon coating services; E-vita Open NEO, a hybrid stent graft; Arcevo, an LSA hybrid stent graft system; AMDS hybrid… Read more